Form 4: Perrigo EVP & CHRO Robert Willis Granted Over 10,000 Restricted Stock Units

Perrigo Company plc's Executive Vice President and Chief Human Resources Officer, Robert Willis, was granted 10,321 Restricted Stock Units, vesting in three annual installments starting June 6, 2026.

Summary

• Robert Willis, Executive Vice President and Chief Human Resources Officer of Perrigo Company plc, was granted 10,321 Restricted Stock Units (RSUs) on June 6, 2025.
• Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
• The RSUs will vest in three equal annual installments, with the first vesting date on June 6, 2026.
• Following this transaction, Mr. Willis beneficially owns 40,451 ordinary shares directly and 10,321 derivative securities (RSUs).

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive is generally a positive sign, indicating executive retention and alignment of interests with shareholders. It's a standard compensation practice and doesn't suggest any immediate negative operational or financial issues, though it does imply future share dilution.

Positives

• The grant of Restricted Stock Units aligns the interests of EVP & CHRO Robert Willis with those of shareholders, as the value of the units is tied to the company's stock performance.
• The multi-year vesting schedule (3 equal annual installments) acts as a retention mechanism for a key executive.

Negatives

• The future conversion of Restricted Stock Units into ordinary shares could lead to a minor dilutive effect on existing shareholders, although this is a standard component of executive compensation.

Risks

• The value of the granted Restricted Stock Units is contingent on the future performance of Perrigo Company plc's ordinary shares, meaning the actual value realized by the executive could be lower if the stock price declines.

Future Outlook

The grant of Restricted Stock Units with a multi-year vesting schedule indicates a long-term commitment to the executive and aims to incentivize future performance aligned with shareholder value.

Industry Context

Executive equity grants, such as Restricted Stock Units, are a common practice across various industries, including the pharmaceutical and consumer healthcare sectors, to attract, retain, and incentivize key talent by linking their compensation to company performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of executive compensation is a widely adopted practice among publicly traded companies, including peers in the consumer healthcare and pharmaceutical sectors such as Johnson & Johnson, Procter & Gamble, and GSK.
• The three-year vesting schedule is typical for long-term incentive awards, comparable to structures seen at companies like Pfizer or Abbott Laboratories, designed to ensure executive retention and align long-term interests.
• The specific number of units granted (10,321) would need to be assessed against Mr. Willis's overall compensation package and the company's compensation philosophy relative to similar roles at comparable market capitalization companies to determine if it is above, below, or in line with industry benchmarks.

Related Party Transactions

• The grant of Restricted Stock Units to Robert Willis, an executive officer of Perrigo Company plc, constitutes a related party transaction as it involves compensation provided by the company to a member of its management.

Stakeholder Impact

• Shareholders: Potential minor future dilution upon vesting and conversion of RSUs into ordinary shares, but also improved alignment of executive incentives with long-term shareholder value.
• Employees: May signal stability in executive leadership and a standard approach to long-term incentives within the company.
• Management: Robert Willis receives a significant equity award, enhancing his overall compensation and providing a long-term incentive to contribute to the company's success.

Next Steps

• The granted Restricted Stock Units will begin vesting in three equal annual installments starting June 6, 2026.
• Future Form 4 filings will report the conversion of these RSUs into ordinary shares upon vesting.

Key Dates

Recommendation

Keywords

Perrigo, PRGO, Restricted Stock Units, RSU, Executive Compensation, Insider Trading, Form 4, Robert Willis, Equity Grant, Share Ownership